Categories
Capitol Riot

TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and …

Spread the love

The additional indication for first-line G/GEJ cancers is based on results from BeiGene’s RATIONALE-305 (NCT03777657), a randomized, double-blind, placebo-controlled, global Phase 3 trial to evaluate the efficacy and safety of TEVIMBRA in combination with chemotherapy as a first-line treatment for adult patients with advanced unresectable or metastatic G/GEJ cancer. The study met its primary …

Spread the love
Categories
Selected Articles

RT @ZelenskyyUa: I spoke to @presidentaz Ilham Aliyev and expressed condolences to him and the people of Azerbaijan regarding the tragic cr…

Spread the love


Spread the love